Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Molecular Cancer Therapeutics|July 5, 2021
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive CholangiocarcinomaKeiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, et al.
Inflammatory Bowel Diseases|July 6, 2010
Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitisFumitaka Terabe, Minoru Fujimoto, Satoshi Serada, et al.
International Immunology|March 2, 2010
Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expressionBarry J M Ripley, Minoru Fujimoto, Satoshi Serada, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2018
Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression ProfilesTomomi Egawa-Takata, Kiyoshi Yoshino, Kosuke Hiramatsu, et al.
Cancer Research|October 19, 2017
SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell CarcinomaTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
British Journal of Haematology|August 26, 2004
Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell linesDai Watanabe, Sachiko Ezoe, Minoru Fujimoto, et al.
Elife|April 2, 2020
GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 AbDaiki Kato, Tomonori Yaguchi, Takashi Iwata, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2023
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal AdenocarcinomaTadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2008
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelinKota Iwahori, Tadashi Osaki, Satoshi Serada, et al.
Cancer Science|November 11, 2025
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential TherapyNaoki Ikenaga, Tsuyoshi Takahashi, Koji Tanaka, et al.
Pageof 18